Zambon is one of the world's leading pharmaceutical and chemical multinationals, earning a strong reputation over the years for its high-quality products, flexibility and customer service.
Thanks to its new "Open Innovation" approach, Zambon pairs its internal research with the exploration of international scenarios, collaborating with Research Institutues, Technology Transfers, Start-ups and Biotec Companies.
11 june 2013
Additional safinamide Phase III study results to be presented at MDS Congres
10 june 2013
Zambon marks the beginning of its €133 million investment plan with the acquisition of Profile Pharma Ltd. from Philips
Zambon Company S.p.A. - ©2013, All rights reserved
Switchboard: +39 02665241